Future REvascularization Evaluation in Patients with Diabetes Mellitus:
Optimal Management of Multivessel Disease (“FREEDOM”)

Sponsor: NIH

Investigators: Michael Mack, MD and David Brown, MD
Research Coordinator: Victor Thothong, RN, BSN

Designated Site: The HEART HOSPITAL Baylor Plano


An NIH sponsored trial to evaluate whether percutaneous coronary intervention (PCI) with drug-eluting stenting (PCI/DES) is more or less effective than the existing standard of care, coronary artery bypass graft surgery (CABG) for the treatment of multivessel coronary artery disease.